- Home
- SPCE vs STRO Comparison
SPCE vs STRO Comparison
Compare SPCE & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SPCE | STRO |
|---|---|---|
| Founded | 2017 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Transportation Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 331.6M | 332.8M |
| IPO Year | 2017 | 2018 |
Fundamental Metrics
Financial Performance| Metric | SPCE | STRO |
|---|---|---|
| Price | $3.21 | $15.45 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 9 |
| Target Price | $3.06 | ★ $31.33 |
| AVG Volume (30 Days) | ★ 5.0M | 277.7K |
| Earning Date | 05-14-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 60.84 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $1,544,000.00 | ★ $38,419,000.00 |
| Revenue This Year | $2,270.73 | N/A |
| Revenue Next Year | $880.03 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.13 | $0.72 |
| 52 Week High | $8.90 | $43.85 |
Technical Indicators
Market Signals| Indicator | SPCE | STRO |
|---|---|---|
| Relative Strength Index (RSI) | 55.75 | 28.03 |
| Support Level | $2.83 | $14.81 |
| Resistance Level | $3.29 | $17.33 |
| Average True Range (ATR) | 0.17 | 1.01 |
| MACD | 0.02 | 0.03 |
| Stochastic Oscillator | 64.65 | 17.17 |
Price Performance
Historical ComparisonAbout SPCE Virgin Galactic Holdings Inc.
Virgin Galactic Holdings Inc is a United States-based vertically integrated aerospace company pioneering human spaceflight for private individuals & researchers, and it also manufactures air and space vehicles. Using technologies, the company is developing a spaceflight system designed to offer its customers a multi-day and transformative experience. This culminates in a spaceflight that includes views of Earth from space and several minutes of weightlessness that will launch from Spaceport America, New Mexico.
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. Company's wholly-owned product candidate is STRO-004, a single homogeneous ADC directed against tissue factor which are developing for the treatment of solid tumors. The company also pipeline contains STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.